Inapsine en es it fr

Inapsine Brand names, Inapsine Analogs

Inapsine Brand Names Mixture

  • No information avaliable

Inapsine Chemical_Formula


Inapsine RX_link

Inapsine fda sheet

Inapsine msds (material safety sheet)

Inapsine MSDS

Inapsine Synthesis Reference

No information avaliable

Inapsine Molecular Weight

166.24 g/mol

Inapsine Melting Point

No information avaliable

Inapsine H2O Solubility

Appreciable as liquid hydrochloride salt

Inapsine State


Inapsine LogP


Inapsine Dosage Forms

Liquid for injection

Inapsine Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Inapsine Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Inapsine Absorption

Rapidly absorbed.

Inapsine side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Inapsine Patient Information

No information avaliable

Inapsine Organisms Affected

Humans and other mammals